Geneva, April 27 -- International Clinical Trials Registry received information related to the study (TCTR20260405010) titled 'EFFECT OF COMBINED THERAPY WITH CARVEDILOL AND SAROGLITAZAR ON HEPATIC FIBROSIS IN PATIENTS WITH MASLD' on April 5.
Study Type: Observational
Primary Sponsor: INDRAJIT SURESH
Condition:
MASLD
Hepatic Fibrosis
Hypertension
Dyslipidemia
Diabetes
MASLD
NAFLD
HTN
DM
MASLD
NAFLD
HTN
DM
Intervention:
Patients with MASLD
Supportive Care
Recruitment Status: Recruiting
Date of First Enrollment: 05/03/2026
Target Sample Size: 200
Countries of Recruitment:
India
To know more, visit https://www.thaiclinicaltrials.org/show/TCTR20260405010
Disclaimer: Curated by HT Syndication....